Medical Device Venture Capital

cultivate(MD) | Medical Device Venture Capital Fund

Our Funds

Established a portfolio of early stage medical device companies that looked to solve real problems.

Created investment opportunities that allowed direct engagement into company operations.

Continued investing in technologies that improve outcomes & reduce healthcare system costs.

The Opportunity Fund leverages the foundation that the cultivate(MD) Seed and Accelerator Funds have built since 2017.

Learn more about our latest medical device venture capital fund which is currently open for investment.

Representative Investments

Embody, Inc., is a regenerative medicine company focused on the development and commercialization of implantable medical devices to address the unmet demands in soft tissue restoration and regeneration.

Imascap develops software for preoperative planning of shoulder replacement surgery.

Shoulder Innovations’ InSet™ Total Shoulder Replacement System addresses the most significant issue in shoulder arthroplasty: unreliable fixation of the glenoid implant. IPO on July 31, 2025. Now trading on NYSE under ‘SI’.

SPDx’s solution expands the revenue capacity of any surgical facility. SPDx provides sterile processing and logistic support that unlocks the potential to perform multiple total joints in an ASC.